Sopharma AD — M&A Activity 2023

Jan 27, 2023

Current report №7/ 2023 Dated January 27, 2023

NOTIFICATION

"Sopharma" AD (the Company) notifies that in compliance with the decision of the Board of Directors of "Sopharma" AD dated 26.10.2022, the Company submitted for approval to the Financial Supervision Commission an Agreement for conversion by merger of the subsidiary company "Biopharm-engineering" AD, UIC: 119055339 in "Sopharma" AD under the conditions and in accordance with Chapter XVI of the Commercial Law and Art. 122 of the Law on Public Offering of Securities.

Ognian Donev